Similar articles for PMID: 14504811

Year	Number of Results
1946	1
1947	2
1951	1
1953	3
1954	3
1955	2
1956	2
1958	1
1961	1
1962	2
1988	1
1994	3
1995	1
1996	5
1997	5
1998	7
1999	7
2000	22
2001	16
2002	18
2003	29
2004	16
2005	15
2006	13
2007	15
2008	9
2009	15
2010	15
2011	13
2012	12
2013	10
2014	16
2015	9
2016	14
2017	7
2018	14
2019	11
2020	10
2021	10
2022	3
2023	1
2024	0

1

Treatment of lymphoma relapses after allogeneic hematopoietic stem cell transplantation with intensive chemotherapy followed by infusion of hematopoietic stem cell from the original donor.

Au WY, Lie AK, Siu LL, Chan EC, Ooi GC, Leung AY, Liang R, Kwong YL. Au WY, et al. Ann Hematol. 2003 Sep;82(9):548-51. doi: 10.1007/s00277-003-0696-z. Epub 2003 Jul 9. Ann Hematol. 2003. PMID: 14504811

2

Establishment of early donor engraftment after reduced-intensity allogeneic hematopoietic stem cell transplantation to potentiate the graft-versus-lymphoma effect against refractory lymphomas.

Bishop MR, Hou JW, Wilson WH, Steinberg SM, Odom J, Castro K, Kasten-Sportes C, Gea-Banacloche J, Marchigiani D, Gress R, Fowler DH. Bishop MR, et al. Biol Blood Marrow Transplant. 2003 Mar;9(3):162-9. doi: 10.1053/bbmt.2003.50008. Biol Blood Marrow Transplant. 2003. PMID: 12652466 Free article. Clinical Trial.

3

Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.

Petersen SL. Petersen SL. Dan Med Bull. 2007 May;54(2):112-39. Dan Med Bull. 2007. PMID: 17521527 Review.

4

High-dose chemotherapy using BEAM without autologous rescue followed by reduced-intensity conditioning allogeneic stem-cell transplantation for refractory or relapsing lymphomas: a comparison of delayed versus immediate transplantation.

Buser AS, Stern M, Bucher C, Arber C, Heim D, Halter J, Meyer-Monard S, Stussi G, Lohri A, Ghielmini M, Tichelli A, Passweg JR, Gratwohl A. Buser AS, et al. Bone Marrow Transplant. 2007 Mar;39(6):335-40. doi: 10.1038/sj.bmt.1705597. Bone Marrow Transplant. 2007. PMID: 17342158 Clinical Trial.

5

Allogeneic stem cell transplantation with BEAM and alemtuzumab conditioning immediately after remission induction has curative potential in advanced T-cell non-Hodgkin's lymphoma.

Czajczynska A, Günther A, Repp R, Humpe A, Schub N, Raff T, Nickelsen M, Schrauder A, Schrappe M, Kneba M, Gramatzki M. Czajczynska A, et al. Biol Blood Marrow Transplant. 2013 Nov;19(11):1632-7. doi: 10.1016/j.bbmt.2013.07.003. Epub 2013 Jul 11. Biol Blood Marrow Transplant. 2013. PMID: 23850653 Free article.

6

BEAM allogeneic transplantation for patients with Hodgkin's disease who relapse after autologous transplantation is safe and effective.

Cooney JP, Stiff PJ, Toor AA, Parthasarathy M. Cooney JP, et al. Biol Blood Marrow Transplant. 2003 Mar;9(3):177-82. doi: 10.1053/bbmt.2003.50007. Biol Blood Marrow Transplant. 2003. PMID: 12652468 Free article.

7

Salvage chemotherapy with mini-BEAM for relapsed or refractory Hodgkin's disease prior to autologous peripheral blood stem cell transplantation.

Fernández-Jiménez MC, Canales MA, Ojeda E, de Bustos JG, Aguado MJ, Hernández-Navarro F. Fernández-Jiménez MC, et al. Haematologica. 1999 Nov;84(11):1007-11. Haematologica. 1999. PMID: 10553161 Clinical Trial.

8

Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation.

You Y, Li QB, Chen ZC, Li WM, Xia LH, Zhou H, Zou P. You Y, et al. Chin Med J (Engl). 2008 Sep 20;121(18):1770-4. Chin Med J (Engl). 2008. PMID: 19080355

9

Effect of the dose per body weight of conditioning chemotherapy on severity of mucositis and risk of relapse after autologous haematopoietic stem cell transplantation in relapsed diffuse large B cell lymphoma.

Costa LJ, Micallef IN, Inwards DJ, Johnston PB, Porrata LF, Litzow MR, Ansell SM. Costa LJ, et al. Br J Haematol. 2008 Oct;143(2):268-73. doi: 10.1111/j.1365-2141.2008.07342.x. Epub 2008 Aug 10. Br J Haematol. 2008. PMID: 18699848 Free article.

10

High-dose carmustine, etoposide, and cyclophosphamide followed by allogeneic hematopoietic cell transplantation for non-Hodgkin lymphoma.

Law LY, Horning SJ, Wong RM, Johnston LJ, Laport GG, Lowsky R, Shizuru JA, Blume KG, Negrin RS, Stockerl-Goldstein KE. Law LY, et al. Biol Blood Marrow Transplant. 2006 Jul;12(7):703-11. doi: 10.1016/j.bbmt.2006.02.009. Biol Blood Marrow Transplant. 2006. PMID: 16785059 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

320 results

Results by year